For example, Fujikawa M et al. [45] indicated that the interaction between stromal CCL1 and CCR8 on cancer cells promotes ESCC progression via the Akt/proline-rich Akt substrate of 40 kDa/mammalian target of rapamycin pathway. Here, CCL1 is linked to esophageal squamous cell carcinoma.